Glycoconjugates and their use as potential vaccines against infection by shigella flexneri
申请人:Institut Pasteur
公开号:EP2369345A1
公开(公告)日:2011-09-28
The present invention relates to a saccharide selected from the group consisting of:
B(E)CD}
(E)CDAB}n
AB(E)CD}n
Wherein A, B, C, E, D and n are as defined in claim 1. The invention also relates to derivatives thereof, pharmaceutical compositions comprising said derivatives, and kit for the diagnostic of Shigella flexneri type 2a infection comprising said derivatives.
本发明涉及一种选自以下组别的糖:
B(E)CD}
(E)CDAB}n
AB(E)CD}n
其中 A、B、C、E、D 和 n 如权利要求 1 所定义。本发明还涉及其衍生物、包含所述衍生物的药物组合物以及包含所述衍生物的用于诊断 2a 型志贺氏菌感染的试剂盒。